Oncolytics Biotech Inc T.ONC

WOW!

[cardu]

Despite the carnage in the markets, ONC is actually up. Positive!

[cardu]

Could this be LIFTOFF. Daily volume almost triple!

[Buckhenry]

many of us who have been holding the last 3 years have seen and heard all this. I hope it does but I will not get excited till it hits around $10 us

[cardu]

I'm with you. I've been holding, and trading, since 2003.

[Buckhenry]

biotech is like playing the roulette wheel.... im hopping our number has finally come up.

[canadafan]

interesting roulette analogy. A single number on wheel pays 35 to one. Recent ONC range $1.80 35/1 = $63 ps That sounds about right................. That would be a $2.4 billion buy-out.... not out of line of the many moubers we have seen lately.

[fox7mf]

$2.4b usd for a ph3 biotech, while early stage/preclinical biotechs have, in some cases, been fetching twice that number. No thanks....I'll expect $8b-$10busd;)

[Normandt]

They have probably already refused offers below 3 billion. I also expect a purchase at a price above 6 billion given the results for pancreatic cancer, breast cancer (the results seem to continue to be positive). Not to mention car-t therapies ( remember the little chart showing 100% positive results pela+ pela boost) and probably many other combinations for different cancers.

[canadafan]

I agree the recent take overs have  been in the $8B - $10B, range. could Onc warrent that? assuming the additional panc cancer results ( Goblet), are as good as the first run- in , then Pelareorep/ Roche combo, could become the standard of care, for a cancer that presently has near zero help. making Pela a blockbuster drug. Add opinion the MBc, CAR-t potential.....pick a number. $10bill , btw

[m00nsh0ts]

20 billion for sure, look at IMMU that went for 21 billion and it's not as versatile. If we get a bidding war starting at 10 billion it's definitely doable.

[Normandt]

I would be very curious to know what offers they have had to date. I find it hard to believe that they can keep these things secret for weeks or even months, without there being the slightest leak, even for a bidding war. 20 billion...ohlala...

[Capitalista]

There may not have been any hard money offers yet.  In my experience, when Co. A expresses interest in buying Co. B and B's BoD is amenable to offers, they go through a due diligence process - B opens its books and history to A's auditors/tech experts. If all is good, A might put in an offer.  This is especially true in multi-billion dollar transactions where there is more at

[fox7mf]

There may have been offers. I'm guessing if that's the case, they weren't considered consequential enough to share with shareholders. I get the feeling they've probably turned away 'lowball' offers ($2-$4b usd.) We'll only know for certain once an offer is deemed appropriate enough for us to sign off on. All this to say that it's the appropriate time to hand Onc off

[inthno]

Funny how a 4 billion dollar U.S. offer could be considered a lowball offer and yet that is a possibility. If indeed that were the case then what exactly is Matt and company looking for. I mean really, I do not think any shareholder would turn down approx. 60 dollars a share at this point. I think that an offer like that would have to be presented to shareholders for consideration unless the

[cardu]

Here! Here!

[Buckhenry]

how many times do I have to say on here that biotechs are like playing the roulette wheel.....

[boater99]

Exactly, Matt has already given the Asian market to Adlai Nortye, has been stumbling along with this for over 25 years, and I believe him and a few others have cut themselves a royality deal.